Home › SAVYON DIAGNOSTICS LTD › SeroELISA Chlamydia IgA

SeroELISA Chlamydia IgA

SAVYON DIAGNOSTICS LTD · Model A113-01 · UDI-DI 07290001913161

LJC Prescription

510(k) clearances

Adverse events

Recalls

Facilities

Description

The SeroELISAChlamydia IgA kit is intended for the determination of specific IgA antibodies to Chlamydia in a single human serum sample by an Enzyme-Linked Immunosorbent Assay (ELISA). For In Vitro Diagnostic Use.

Recalls

Date	Firm	Reason
2025-11-03	GET TESTED INTERNATIONAL AB	Distribution without premarket approval/clearance.
2011-07-08	bioMerieux, Inc.	Complaints were received of high rates of false positive results, leading to unnecessary antibiotic therapy being prescribed to patients.
2008-08-27	Calbiotech Inc	The recall has been initiated due to the "For Export Only" labeling found on some Calbiotech, Inc. ELISA kits. Although there is no potential health hazard related to this recall,
2008-08-27	Calbiotech Inc	The recall has been initiated due to the "For Export Only" labeling found on some Calbiotech, Inc. ELISA kits. Although there is no potential health hazard related to this recall,
2003-08-06	bioMerieux	Product's decrease in sensitivity may result in false negative results
2003-02-07	Thermo Biostar, Incorporated	Chlamydia IVD test kits may contain diluted conjugate reagent. Use may produce a false negative result with a low positive patient sample.
2003-02-07	Thermo Biostar, Incorporated	Chlamydia IVD test kits may contain diluted conjugate reagent. Use may produce a false negative result with a low positive patient sample.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API key Read the docs

Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.